![Florian Jehle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Florian Jehle
Algemeen Directeur bij
Vifor Fresenius Medical Care Renal Pharma Ltd.
Profiel
Florian Jehle currently works at Vifor Fresenius Medical Care Renal Pharma Ltd., as Chief Executive Officer from 2022 and Fresenius Medical Care Ventures GmbH, as Managing Director from 2016.
Actieve functies van Florian Jehle
| Bedrijven | Functie | Begin |
|---|---|---|
Fresenius Medical Care Ventures GmbH
 Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Directeur/Bestuurslid | 10-02-2016 |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Algemeen Directeur | 01-04-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Health Technology |
Fresenius Medical Care Ventures GmbH
Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Finance |
